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236a Monday, March 2, 2009the procedure. The other electrode was used to dialyze the fiber with a solution
containing either 6-15 mMBAPTA, or up to 60 mM EGTA (pCa¼7.0), and ad-
justed to pH¼7.0with 20 or 60mMMOPS, respectively. FreemyoplasmicCa2þ
concentration ([Ca2þ]) changes were measured with the low affinity indicator
OGB-5N (200 mM). SR Ca2þ release was elicited by either 20 mM caffeine,
or 1 mM 4-chloro-methy-phenol (4CmC), added to the external solution. The
maximal fluorescence change of the Ca2þ indicator was assessed at the end of
the protocol by exposing the fibers to saponin (0.1 mg/ml in isotonic CaCl2,
pH¼7.0 with 20 mM MOPS). To prevent changes in shape of the fibers under
these conditions, they were pretreated for 1 min with 1% formaldehyde (in Ty-
rode). The experiments were conducted at 20 C. A single model compartment
was used to estimate (from the [Ca2þ] changes) the total Ca2þ released in re-
sponse to caffeine/4CmC application. We obtained values of SR Ca2þ content
in the range of 15-27 mM for normal FDB fibers. Interestingly, comparable
values were obtained in fibers from mdx mice.
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The double mutant utr-/-/mdx mouse has been postulated to be a better model of
Duchenne Muscular Dystrophy than mdx mouse because it displays a progres-
sion of pathological features comparable to that in humans. We previously
demonstrated that FDB fibers from mdx mice show limitations in action poten-
tial (AP) elicited Ca2þ release. Here we investigated the properties of the APs
and the ability to release Ca2þ (30 mM [EGTA], 20oC) in response to single and
trains of APs (20 pulses, at 33Hz and 100Hz) in FDB fibers isolated from con-
trol, mdx and utr-/-/mdx mice. Single APs of normal amplitude but longer
duration were recorded in utr-/-/mdx fibers, whereas the amplitude of the Ca2þ
release was ~37% smaller than in normal fibers, but comparable with that found
in mdx fibers. Fibers from the three strains sustained trains of Ca release at 33
Hz in which the amplitude of individual Ca2þ release transients decayed expo-
nentially towards a sustained release amplitude with two time constants
(t1¼10ms, t2¼200ms). In response to 100Hz trains, the amplitude of Ca2þ re-
lease in normal fibers decayed still with a double exponential (t1¼3.5ms,
t2¼41ms) in which the amplitude of the 2nd and 20th transient along the train
were ~50% and ~35% that of the first one, respectively. In contrast, fibers iso-
lated from bothmdx and utr-/-/mdxmice could be divided in two groups accord-
ing to their tetanic response to 100Hz trains: approximately 75% of mdx and
33% of utr-/-/mdx fibers showed a behavior similar to that observed in normal
fibers; in the remaining 25% of mdx and 67% of utr-/-/mdx fibers, respectively,
the amplitude of the 2nd Ca2þ release transient was ~20% of the first one, and
this amplitude was sustained throughout the train.
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The mutation from isoleucine to threonine of the skeletal isoform of the ryano-
dine receptor (RyR1) at residue 4898 results in severe Central Core Disease
(CCD). Under homozygous expression (IT/IT), we reported a lack of Ca2þ re-
lease in response to electrical and pharmacological activation despite SR Ca2þ
store content indistinguishable from control. Here we used heterozygous
knock-in mice for the I4895T (IT/þ; analogous to human I4898T) RyR1 mu-
tation to determine the effects of the mutation on muscle strength and Ca2þ
handling in flexor digitorum brevis (FDB) and interosseous muscle fibers.
We compared in vivo muscle strength of wild-type (WT) and IT/þ mice. IT/þ
mice exhibited significant weakness in both upper body and grip strength as-
says (4-paw peak grip force: 2400 5 70 mN, n¼8 and 2040 5 80 mN,
n¼14 in WT and IT/þ mice, respectively). We also determined the magnitude
of action potential- and ligand-evoked Ca2þ release in single intact FDB fibers
using Ca2þ fluorometry. The magnitude of both electrically- and ligand-evoked
Ca2þ release was significantly reduced in IT/þ fibers. Moreover, the maximum
rate of change in mag-fluo-4 fluorescence during the rising phase of the electri-
cally-evoked Ca2þ transient was significantly reduced in IT/þ fibers (WT
0.175 0.01 DF/F/ms vs IT/þ 0.115 0.01 DF/F/ms, n¼ 53, 56, respectively).
Finally, the frequency (1.95 0.5 and 0.85 0.3 events/scan) and Ca2þ spark
mass (5.95 0.3 and 4.65 0.2 mm3) of local Ca2þ release induced by osmotic
shock (440 mOsm with sucrose, 750 lines/sec) were reduced in acutely disso-
ciated IT/þ interosseous fibers compared to that of WT fibers. Together, these
findings are consistent with the hypothesis that the IT mutation in the putative
RyR1 selectivity filter significantly reduces Ca2þ flux through the channel.1213-Pos Board B57
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Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle
triggered insusceptible individuals by inhalation anesthetics and depolarizing
skeletal muscle relaxants. This syndrome has been linked to a missense muta-
tion in the type 1 ryanodine receptor (RyR1) in more than 50% of cases studied
to date. We have examined how the R163CMH-RyR1 mutation alters the Ca2þ
transient during [Kþ]e depolarization using Fluo4 and excitation-coupled Ca
2þ
entry (ECCE) using manganese-quench of Fura2 Wt and RyR1R163C knock-in
myotubes. Exposure of WT and RyR1R163C myotubes to low Ca
2þ solution
(8.7x10-6 M) and then to high [Kþ]e did not modify initial Ca2þ transient
(Ca2þpeak), but dramatically altered the time course of the Ca
2þ-transient, mak-
ing the duration shorter and the rate of decay faster in all genotypes. However,
these changes were more evident in RyR1R163C than Wt myotubes. The rate of
Mn2þ quench of Fura2 associated with Kþ depolarization (ECCE), was mem-
brane potential dependent and always greater and faster in RyR1R163C myo-
tubes than in Wt. Incubation of Wt and MH RyR1R163C myotubes with 15 mM
ryanodine overnight, to block RyR1 Ca2þ release, enhanced the amplitude but
did not significantly change in the rate of ECCE in either genotype. However,
the increment in amplitude was greater in Wt than RyR1R163C knock-in myo-
tubes. We conclude that the pre-existing conformational change caused by
the RyR1R163C MHmutation alters the properties ECCE as consequence of sig-
nificant changes in the retrograde signaling between RyR1 and DHPR making
it less sensitive to the conformational change caused of ryanodine.
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Malignant hyperthermia (MHS) and environmental heat stroke (EHS) in hu-
mans present as similar life threatening crises triggered by volatile anesthetics
and strenuous exercise and/or high temperature, respectively. Many families
(70-80%) diagnosed with MH susceptibility (MHS), and a few with EHS, are
linked to mutations in the gene that encodes the type 1 ryanodine receptor
(RYR1) located in the sarcoplasmic reticulum (SR) of skeletal muscle. How-
ever, mutations in the RYR1 gene are not found in all MH families, suggesting
that alternative genes remain to be identified. Here we investigated whether
a MH/EHS-like phenotype results from deficiency in skeletal muscle calse-
questrin (CASQ1), a SR Ca2þ-binding protein that modulates RYR1 function.
Exposure of CASQ1-null mice to halothane or heat stress triggers lethal epi-
sodes characterized by elevated core temperature, whole body contractures,
and severe rhabdomyolysis. Both heat- and halothane-induced episodes are pre-
vented by prior dantrolene administration, the standard antidote used to treat
MH episodes in humans. In vitro studies indicate that CASQ1-null muscle
exhibits increased contractile sensitivity to caffeine, temperature-dependent
increases in resting Ca2þ, and an increase in the magnitude of depolariza-
tion-induced Ca2þ release. These findings validate CASQ1 as a candidate gene
for linkage analysis in MH/EHS families where mutations in RYR1 are
excluded.
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Amplitude of calcium (Ca2þ) transients and width of the Sarcoplasmic Retic-
ulum (SR) lumen in Ca2þ release units (CRUs) are significantly reduced in
Calsequestrin1 (CS1)- null mice, moreover increase in fatigue resistance is
characteristic of the CS1-null-model (Paolini et al 2007). We extend the study
of the null model at molecular level: decrease in expression of CS2, Triadin,
Sarcalumenin were detected in CS1-null FDB muscles in comparison to wild
type (wt) and differential FDB (null/wt) expression of 13400 mRNAs was as-
sayed by microarray profiling. To rescue the CS1-null phenotype, exogenous
mouse CS1 was expressed in adult null-FDBs by in vivo DNA electrotransfer.
CS1 expression and correct targeting to CRUs was verified by confocal
